PMID: 7955536Nov 1, 1994Paper

Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes

Clinical and Experimental Immunology
Alexander R RosenkranzGerhard J Zlabinger

Abstract

Production of reactive oxygen intermediates (ROI) by neutrophils (PMN) in vivo was examined by a whole blood assay using dichlorofluorescein-diacetate (DCFH-DA) in 10 patients each dialysed consecutively with two different dialyser membranes. Haemodialysis (HD) with cuprophan membrane (CM) led to a significantly (P < 0.001) more pronounced ROI production by PMN (2.4 +/- 0.5-fold increase in intracellular oxidation of DCFH-DA) compared with HD with polysulfone membranes (PM; 1.5 +/- 0.2-fold). HD with CM induced a decrease in PMN count by about 90%, whereas PM induced a decrease by only 25% (P < 0.001). In CM patients maximal ROI production coincided with the nadir in PMN count. All patients dialysed with CM showed a clear increase in serum levels of Bb fragments, whereas PM-dialysed patients did not. In this respect, however, no clear time relationship was seen to the kinetics of ROI production, nor to the disappearance of neutrophils from the circulation. Evaluating a direct effect of the dialysis membranes on PMN demonstrated that incubation of neutrophils with hollow fibres of the CM but not of the PM in the absence of plasma induces significant ROI production by PMN. Our study thus indicates that ROI production by PMN durin...Continue Reading

References

Apr 7, 1977·The New England Journal of Medicine·P R CraddockH S Jacob
Nov 25, 1992·Journal of Immunological Methods·Alexander R RosenkranzGerhard J Zlabinger
Jul 1, 1991·The Biochemical Journal·C Capeillere-BlandinB Descamps-Latscha
Feb 1, 1991·The Journal of Cell Biology·K D PatelT M McIntyre
Mar 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J HimmelfarbR Hakim
Jan 1, 1990·Kidney International·R SchindlerC A Dinarello
Oct 1, 1989·The Journal of Clinical Investigation·M BaggioliniS L Kunkel
May 1, 1989·Kidney International·N Haeffner-CavaillonM Kazatchkine
Jan 1, 1988·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T KuwaharaJ P Wauters
May 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T B WiegmannD A Diederich
Jan 1, 1988·Kidney International·G LonnemannC A Dinarello
Feb 21, 1985·The New England Journal of Medicine·M A ArnaoutH R Colten
Oct 4, 1984·The New England Journal of Medicine·R HakimF K Port
Dec 1, 1983·Kidney International·A AmadoriM Ricci
Dec 1, 1983·Kidney International·D E ChenowethL W Henderson

Citations

Mar 29, 2003·Artificial Organs·Richard A Ward, Kenneth R McLeish
Jul 23, 2003·Journal of Clinical Apheresis·Aki HirayamaAkio Koyama
Apr 18, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Mirjam PocivalnikKathrin Eller
Jun 3, 1999·Clinical Chemistry and Laboratory Medicine : CCLM·G F KörmöcziGerhard J Zlabinger
Mar 17, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K HocheggerKarl Lhotta
Apr 12, 2016·Luminescence : the Journal of Biological and Chemical Luminescence·Chih-Yang HuangTung-Sheng Chen
Mar 20, 2001·Journal of Biomedical Materials Research·M A MooreM J Kowolik
Feb 9, 1999·Artificial Organs·M BonominiN Settefrati
Oct 10, 2006·International Journal of Immunopathology and Pharmacology·V SirolliM Bonomini

Related Concepts

Cuprammonium cellulose
UDEL
Complement C4d
Hemocompatible Materials
Sulfite Cellulose
Complement Activation
Complement C3b
Complement C4, Precursor
Hemodialysis
Differential White Blood Cell Count Procedure

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.